114 related articles for article (PubMed ID: 2197031)
1. An evaluation of an enzyme immunoassay method for immunoreactive trypsin in dried blood spots.
Cabrini G; Pederzini F; Perobelli L; Mastella G
Clin Biochem; 1990 Jun; 23(3):213-9. PubMed ID: 2197031
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody-based enzyme immunoassay for trypsinogen in neonatal screening for cystic fibrosis.
Bowling FG; Watson AR; Rylatt DB; Elliott JE; Bunch RJ; Bundesen PG
Lancet; 1987 Apr; 1(8537):826-7. PubMed ID: 2882233
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and comparison of radio-, fluorescence, and enzyme-linked immunoassays for serum thyroxine.
Kaplan LA; Chen IW; Gau N; Fearn J; Maxon H; Volle C; Stein EA
Clin Biochem; 1981 Aug; 14(4):182-6. PubMed ID: 7028316
[TBL] [Abstract][Full Text] [Related]
4. Modifying an enzyme immunoassay of immunoreactive trypsinogen to use time-resolved fluorescence.
Ryall RG; Gjerde EM; Gerace RL; Ranieri E
Clin Chem; 1993 Feb; 39(2):224-8. PubMed ID: 8432010
[TBL] [Abstract][Full Text] [Related]
5. Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis.
Ranieri E; Ryall RG; Morris CP; Nelson PV; Carey WF; Pollard AC; Robertson EF
BMJ; 1991 May; 302(6787):1237-40. PubMed ID: 2043846
[TBL] [Abstract][Full Text] [Related]
6. Comparison of enzyme immunoassay with radioimmunoassay for the detection of hepatitis B surface antigen.
Hendry RM; Herzog LW; Herrman JE; Meehan RE
J Med Microbiol; 1983 May; 16(2):111-6. PubMed ID: 6341594
[TBL] [Abstract][Full Text] [Related]
7. Thyrotropin enzyme-immunoassay in dried blood spots: a spectrophotometric method for neonatal thyroid screening.
Torresani T; Qiu Q; Illig R
J Clin Chem Clin Biochem; 1986 Mar; 24(3):199-203. PubMed ID: 3519833
[TBL] [Abstract][Full Text] [Related]
8. An Enzyme Immunoassay for Determining Immunoreactive Trypsinogen (IRT) in Dried Blood Spots on Filter Paper Using an Ultra-Microanalytical System.
Castells Martínez EM; González EC; Tejeda Y; Frómeta A; Martín O; Espinosa M; Del Río L; Pérez PL; Morejón G; Perea Y; Melchor A
Appl Biochem Biotechnol; 2018 Dec; 186(4):1034-1046. PubMed ID: 29808455
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations.
Hammond KB; Abman SH; Sokol RJ; Accurso FJ
N Engl J Med; 1991 Sep; 325(11):769-74. PubMed ID: 1870650
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of six erythropoietin kits.
Marsden JT; Sherwood RA; Peters TJ
Ann Clin Biochem; 1999 May; 36 ( Pt 3)():380-7. PubMed ID: 10376082
[TBL] [Abstract][Full Text] [Related]
11. EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer.
Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Yen CC; Chen WS; Jiang JK; Yang SH; Wang HS; Chen PM
Hepatogastroenterology; 2004; 51(55):136-41. PubMed ID: 15011849
[TBL] [Abstract][Full Text] [Related]
12. Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels.
Rock MJ; Mischler EH; Farrell PM; Wei LJ; Bruns WT; Hassemer DJ; Laessig RH
Pediatrics; 1990 Jun; 85(6):1001-7. PubMed ID: 2187173
[TBL] [Abstract][Full Text] [Related]
13. Correlation between RIA-EIA-ELISA methods for alpha-fetoprotein research.
Pastore M; Francioni S
J Nucl Med Allied Sci; 1989; 33(3 Suppl):107-10. PubMed ID: 2480406
[TBL] [Abstract][Full Text] [Related]
14. Plasma immunoreactive cationic trypsin(ogen) pattern in reserpinized rat model of cystic fibrosis. Resemblance to humans.
Weizman Z
Dig Dis Sci; 1996 May; 41(5):853-8. PubMed ID: 8625754
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of micro particle enzyme immunoassay (MEIA) for the demonstration of antibody to hepatitis B surface antigen].
Kashiwagi S; Hayashi J; Noguchi A; Nakashima K; Hirata M; Kajiyama W
Kansenshogaku Zasshi; 1992 Mar; 66(3):390-9. PubMed ID: 1624829
[TBL] [Abstract][Full Text] [Related]
16. Serum immunoreactive cationic trypsinogen: a useful indicator of severe exocrine dysfunction in the paediatric patient without cystic fibrosis.
Moore DJ; Forstner GG; Largman C; Cleghorn GJ; Wong SS; Durie PR
Gut; 1986 Nov; 27(11):1362-8. PubMed ID: 3792918
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a fluorescent immunoassay with an enzyme immunoassay and a radioimmunoassay for gentamicin.
Lau AH; Chow-Tung E
Am J Hosp Pharm; 1984 Dec; 41(12):2647-50. PubMed ID: 6393760
[TBL] [Abstract][Full Text] [Related]
18. Age-related alterations in immunoreactive pancreatic lipase and cationic trypsinogen in young children with cystic fibrosis.
Cleghorn G; Benjamin L; Corey M; Forstner G; Dati F; Durie P
J Pediatr; 1985 Sep; 107(3):377-81. PubMed ID: 4032133
[TBL] [Abstract][Full Text] [Related]
19. Serum prostatic acid phosphatase (PAP): monoclonal enzyme-linked immunoassay compared to polyclonal radioimmunoassay.
Taylor EH; Gadsden RH
Ann Clin Lab Sci; 1984; 14(1):21-6. PubMed ID: 6364952
[TBL] [Abstract][Full Text] [Related]
20. A sensitive and specific two-site enzyme-immunoassay for human calcitonin using monoclonal antibodies.
Seth R; Motté P; Kehely A; Wimalawansa SJ; Self CH; Bellet D; Bohuon C; MacIntyre I
J Endocrinol; 1988 Nov; 119(2):351-7. PubMed ID: 3058855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
